Electrophysiological Biomarkers of Kynurenine Pathway Modulator AV-101 in Healthy Volunteers: Treating Suicidal Veterans
Phase of Trial: Phase I/II
Latest Information Update: 15 Nov 2019
Price : $35 *
At a glance
- Drugs AV 101 (Primary)
- Indications Major depressive disorder; Neuropathic pain; Psychiatric disorders; Suicidal ideation
- Focus Biomarker; Pharmacodynamics
- 11 Nov 2019 Status changed from recruiting to completed.
- 09 Jul 2019 Planned End Date changed from 31 Mar 2019 to 31 Oct 2019.
- 09 Jul 2019 Planned primary completion date changed from 31 Mar 2019 to 31 Oct 2019.